In its annual general meeting on Thursday, Novo Nordisk (NVO) announced the appointment of Poul Weihrauch, CEO of U.S. chocolate maker Mars, as an observer to the weight-loss drugmaker’s board. The ...
GlobalData on MSN
Mars CEO gets board role at GLP-1 supplier Novo Nordisk
Poul Weihrauch is to be a “board observer” at the pharma group, which markets GLP-1 drugs under brands including Ozempic and ...
COPENHAGEN, March 26 (Reuters) - Novo Nordisk on Thursday elected Poul Weihrauch, CEO of family-owned U.S. candy and pet food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results